Activities of sordarins in experimental models of candidiasis, aspergillosis, and pneumocystosis

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 12, 2000, Pages 3389-3394

  Martinez, A ^a   Aviles, P ^a   Jimenez, E ^a   Caballero, J ^a   Gargallo Viola, D ^a  

^a GLAXOSMITHKLINE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; DEXAMETHASONE; FUNGAL PROTEIN; GM 193663; GM 237354; SORDARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG HALF LIFE; FEMALE; LUNG CYST; MALE; MOUSE; NONHUMAN; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SURVIVAL TIME; TREATMENT OUTCOME;

ANIMALS; ANTIBIOTICS, ANTIFUNGAL; ASPERGILLOSIS; CANDIDIASIS; DISEASE MODELS, ANIMAL; FEMALE; INDENES; MALE; MICE; PNEUMONIA, PNEUMOCYSTIS; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, WISTAR; TREATMENT OUTCOME;

EID: 0034425536     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.12.3389-3394.2000     Document Type: Article

References (23)

1. Development of pneumocystosis animal models: Corticosteroid-treated Wistar rat; SCID mouse and nude rat
2. Therapy of deep fungal infection in haematological malignancy
3. In vitro pharmacodynamic parameters of sordarin derivatives in comparison with those of marketed compounds against Pneumocystis carinii isolated from rats
4. Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model
5. Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo
6. Translation elongation factor 2 is part of the target for a new family of antifungals
7. Efficacies of sordarin derivatives GM193663, GM211676, or GM237354 in a murine model of systemic coccidioidomycosis
8. Invasive aspergillosis
9. Antifungal and surgical treatment of invasive aspergillosis: Review of 2121 published cases
10. Sordarins: A new class of antifungal with selective inhibition of the protein synthesis elongation cycle in yeast
11. Identification of elongation factor 2 as the essential protein targeted by sordarins in Candida albicans
12. Role of pharmacokinetics in the outcome of infections
13. The problem of azole resistance in candida
14. Prevention of infection due to Pneumocystis carinii
15. Sordarins as antifungical compounds
16. Antifungal agents: Chemotherapeutic targets and immunologic strategies
17. Activities of sordarins in murine histoplasmosis
18. Sordarins: In vitro activities of new antifungal derivates against pathogenic yeasts. Pneumocystis carinii, and filamentous fungi
19. Tail sectioning: A rapid and simple method for repeated blood sampling of the rat for cortisone determination
20. Morphological evaluation of Pneumocystis carinii after extraction from infected lung
21. Practice guidelines for diseases caused by Aspegillus
22. Therapeutic drug monitoring of systemic antifungal therapy
23. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care